Pay in 4 interest-free payments of $6.32 Learn more
Ships within 48 hours · Estimated delivery Aug 29 - Sep 3
10.3389/fnana.2025.1580435 248 KuhlmannT.LudwinS.PratA.AntelJ.BrckW.LassmannH
This strengthens the natural signals that reduce appetite and steady blood sugar levels
Commercially insured T2D patients may be eligible for the NovoCare Ozempic Savings Card ($25/fill, max $150/28-day) verify eligibility, as Kaiser's closed-network pharmacy benefit may affect card usability
A March 2026 trial result (TRANSCEND-T2D-1) showed the drug also delivered meaningful A1C reduction and around 16.8% weight loss in people with type 2 diabetes, a group that historically loses less weight on GLP-1 drugs than people without diabetes
Miyazawa T, Nakagawa K, Shimasaki S, et al
US$ 27.48
US$ 21.56
US$ 21.18
US$ 24.62
